We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$169M
AUM Growth
-$13M
Cap. Flow
-$17.8M
Cap. Flow %
-10.58%
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.01M
2
PGR icon
Progressive
PGR
+$999K
3
SYK icon
Stryker
SYK
+$984K
4
RSG icon
Republic Services
RSG
+$973K
5
LIN icon
Linde
LIN
+$966K

Sector Composition

Rank Sector Weight
1 Healthcare 27.98%
2 Technology 15.96%
3 Financials 11.34%
4 Energy 8.43%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
476
Republic Services
RSG
$68.1B
-7,196
Closed -$973K
SCHW
477
Charles Schwab
SCHW
$185B
-11,418
Closed -$598K
SGMO
478
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-29,327
Closed -$51.6K
SYK icon
479
Stryker
SYK
$134B
-3,447
Closed -$984K
SYY icon
480
Sysco
SYY
$41.1B
-11,199
Closed -$865K
TRV icon
481
Travelers Companies
TRV
$82.3B
-4,762
Closed -$816K
WAT icon
482
Waters Corp
WAT
$37.4B
-2,581
Closed -$799K
WM icon
483
Waste Management
WM
$95.8B
-5,813
Closed -$949K
YUMC icon
484
Yum China
YUMC
$15.8B
-14,574
Closed -$924K
CPAY icon
485
Corpay
CPAY
$25.6B
-4,428
Closed -$934K
KLRS
486
Kalaris Therapeutics
KLRS
$81.1M
-656
Closed -$59.5K
TVRD
487
Tvardi Therapeutics
TVRD
$22.1M
-241
Closed -$42.5K
NGM
488
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-18,916
Closed -$77.2K
SGEN
489
DELISTED
Seagen Inc. Common Stock
SGEN
-2,332
Closed -$472K
KDNY
490
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-4,052
Closed -$93.8K
ISEE
491
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-4,539
Closed -$110K
RXDX
492
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-936
Closed -$100K
PRVB
493
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-31,657
Closed -$763K
CTIC
494
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-52,472
Closed -$220K
ATVI
495
DELISTED
Activision Blizzard
ATVI
-11,798
Closed -$1.01M

Similar funds

Virtus ETF Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, Virtus ETF Advisers held 495 positions worth $169M, down 7.2% from $182M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Virtus ETF Advisers withdrew a net $17.8M in Q2 2023, closing 60 positions and reducing 257 holdings. Its most notable exit was Activision Blizzard, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Virtus ETF Advisers opened a new position in NVIDIA worth $1.21M.

  • Virtus ETF Advisers's largest Q2 2023 buy was NVIDIA: 28,520 shares worth $1.21M.
  • Virtus ETF Advisers added most to Moderna in Q2 2023, an estimated $899K increase.
  • Virtus ETF Advisers's biggest Q2 2023 reduction was Dow Inc, cutting an estimated $898K.
  • Virtus ETF Advisers fully exited Activision Blizzard in Q2 2023, selling an estimated $1.01M.
  • Virtus ETF Advisers's ten largest holdings make up 6.3% of its $169M portfolio in Q2 2023.
  • Virtus ETF Advisers opened 55 new positions and closed 60 in Q2 2023.
  • Virtus ETF Advisers's portfolio value fell 7.2% quarter-over-quarter to $169M.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.